FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3188085711> ?p ?o ?g. }

• W3188085711 endingPage "108043" @default.
• W3188085711 startingPage "108043" @default.
• W3188085711 abstract "Regarding the COVID-19 pandemic, potential therapeutic agents are being evaluated almost every day. Ciclosporin, a calcineurin inhibitor, is characterized by beneficial antiviral and immunomodulatory effects. The present study aimed to evaluate the efficacy of ciclosporin in managing COVID-19. This study was a prospective non-controlled clinical trial carried out on 20 patients. Confirmed COVID-19 patients received two doses of ciclosporin (10 mg/kg and 5 mg/kg injections) 24 h apart. Mortality rate and the lengths of intensive care unit (ICU) and hospital stays were assessed for all 20 patients. The mortality rate and the need for mechanical ventilation were calculated as 50%. The percentage of ICU admission was 70%. The lengths of ICU and hospital stays were 8.13 ± 6.81 and 14.25 ± 8.55 days, respectively. The levels of ferritin and white blood cells were significantly higher after injecting the second dose of ciclosporin. Seven patients (35%) had radiologically improved lungs after ciclosporin therapy. It seems that the protocol of two doses of ciclosporin in combination with favipiravir does not have favorable effects among COVID-19 patients that do not respond to dexamethasone. Controlled trials are needed to confirm the results." @default.
• W3188085711 created "2021-08-16" @default.
• W3188085711 creator A5020334529 @default.
• W3188085711 creator A5040301840 @default.
• W3188085711 creator A5049362679 @default.
• W3188085711 creator A5055347041 @default.
• W3188085711 creator A5056868629 @default.
• W3188085711 creator A5059457055 @default.
• W3188085711 creator A5060105212 @default.
• W3188085711 creator A5061251507 @default.
• W3188085711 creator A5073648948 @default.
• W3188085711 creator A5085766375 @default.
• W3188085711 creator A5088047020 @default.
• W3188085711 date "2021-10-01" @default.
• W3188085711 modified "2023-09-27" @default.
• W3188085711 title "Combined Therapy of Ciclosporin Plus Favipiravir in the Management of Patients with Severe COVID-19, not Responding to Dexamethasone: A non-Controlled Prospective Trial" @default.
• W3188085711 cites W1976499918 @default.
• W3188085711 cites W2009882421 @default.
• W3188085711 cites W2036693329 @default.
• W3188085711 cites W2098356981 @default.
• W3188085711 cites W2117336218 @default.
• W3188085711 cites W2510894023 @default.
• W3188085711 cites W2739679816 @default.
• W3188085711 cites W3006485704 @default.
• W3188085711 cites W3009582878 @default.
• W3188085711 cites W3012455685 @default.
• W3188085711 cites W3015225661 @default.
• W3188085711 cites W3017029231 @default.
• W3188085711 cites W3036166911 @default.
• W3188085711 cites W3037864608 @default.
• W3188085711 cites W3037879647 @default.
• W3188085711 cites W3046641417 @default.
• W3188085711 cites W3083152745 @default.
• W3188085711 cites W3107287672 @default.
• W3188085711 cites W3129895566 @default.
• W3188085711 cites W4239625653 @default.
• W3188085711 doi "https://doi.org/10.1016/j.intimp.2021.108043" @default.
• W3188085711 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8332739" @default.
• W3188085711 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34426105" @default.
• W3188085711 hasPublicationYear "2021" @default.
• W3188085711 type Work @default.
• W3188085711 sameAs 3188085711 @default.
• W3188085711 citedByCount "1" @default.
• W3188085711 countsByYear W31880857112023 @default.
• W3188085711 crossrefType "journal-article" @default.
• W3188085711 hasAuthorship W3188085711A5020334529 @default.
• W3188085711 hasAuthorship W3188085711A5040301840 @default.
• W3188085711 hasAuthorship W3188085711A5049362679 @default.
• W3188085711 hasAuthorship W3188085711A5055347041 @default.
• W3188085711 hasAuthorship W3188085711A5056868629 @default.
• W3188085711 hasAuthorship W3188085711A5059457055 @default.
• W3188085711 hasAuthorship W3188085711A5060105212 @default.
• W3188085711 hasAuthorship W3188085711A5061251507 @default.
• W3188085711 hasAuthorship W3188085711A5073648948 @default.
• W3188085711 hasAuthorship W3188085711A5085766375 @default.
• W3188085711 hasAuthorship W3188085711A5088047020 @default.
• W3188085711 hasBestOaLocation W31880857111 @default.
• W3188085711 hasConcept C126322002 @default.
• W3188085711 hasConcept C2776376669 @default.
• W3188085711 hasConcept C2776694085 @default.
• W3188085711 hasConcept C2777080012 @default.
• W3188085711 hasConcept C2779134260 @default.
• W3188085711 hasConcept C2779528694 @default.
• W3188085711 hasConcept C2779772310 @default.
• W3188085711 hasConcept C2780401358 @default.
• W3188085711 hasConcept C3008058167 @default.
• W3188085711 hasConcept C42219234 @default.
• W3188085711 hasConcept C524204448 @default.
• W3188085711 hasConcept C71924100 @default.
• W3188085711 hasConceptScore W3188085711C126322002 @default.
• W3188085711 hasConceptScore W3188085711C2776376669 @default.
• W3188085711 hasConceptScore W3188085711C2776694085 @default.
• W3188085711 hasConceptScore W3188085711C2777080012 @default.
• W3188085711 hasConceptScore W3188085711C2779134260 @default.
• W3188085711 hasConceptScore W3188085711C2779528694 @default.
• W3188085711 hasConceptScore W3188085711C2779772310 @default.
• W3188085711 hasConceptScore W3188085711C2780401358 @default.
• W3188085711 hasConceptScore W3188085711C3008058167 @default.
• W3188085711 hasConceptScore W3188085711C42219234 @default.
• W3188085711 hasConceptScore W3188085711C524204448 @default.
• W3188085711 hasConceptScore W3188085711C71924100 @default.
• W3188085711 hasFunder F4320323457 @default.
• W3188085711 hasLocation W31880857111 @default.
• W3188085711 hasLocation W31880857112 @default.
• W3188085711 hasLocation W31880857113 @default.
• W3188085711 hasOpenAccess W3188085711 @default.
• W3188085711 hasPrimaryLocation W31880857111 @default.
• W3188085711 hasRelatedWork W1511775759 @default.
• W3188085711 hasRelatedWork W1990941510 @default.
• W3188085711 hasRelatedWork W2011717172 @default.
• W3188085711 hasRelatedWork W2067693794 @default.
• W3188085711 hasRelatedWork W2153052119 @default.
• W3188085711 hasRelatedWork W2348523392 @default.
• W3188085711 hasRelatedWork W261798218 @default.
• W3188085711 hasRelatedWork W3092613758 @default.
• W3188085711 hasRelatedWork W3185137146 @default.
• W3188085711 hasRelatedWork W4245460973 @default.
• W3188085711 hasVolume "99" @default.

• next